David R. Parkinson's most recent trade in Essa Pharma Inc was a trade of 350,000 Options done . Disclosure was reported to the exchange on March 25, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Essa Pharma Inc | David Ross Parkinson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 350,000 | 350,000 | - | - | Options | |
Essa Pharma Inc | Ross Parkinson David | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 14 Dec 2023 | 9,223 | 65,675 (1%) | 0% | 2.3 | 21,213 | Common Shares |
Essa Pharma Inc | David Ross Parkinson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.39 per share. | 22 Dec 2022 | 21,367 | 53,475 (0%) | 0% | 2.4 | 51,067 | Common Shares |
Essa Pharma Inc | David Ross Parkinson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 22 Dec 2022 | 3,067 | 56,542 (0%) | 0% | 2.6 | 7,974 | Common Shares |
Essa Pharma Inc | David Ross Parkinson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.96 per share. | 30 Jun 2022 | 4,887 | 32,108 (0%) | 0% | 3.0 | 14,456 | Common Shares |
Essa Pharma Inc | David Ross Parkinson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 222,500 | 222,500 | - | - | Stock Option (Right to Buy) |